Benitec Biopharma Ltd ADR (BNTC) — Cash Flow-to-Debt Ratio
Benitec Biopharma Ltd ADR (BNTC) has a Cash Flow-to-Debt Ratio of -1.14x as of December 2025, meaning its operating cash flow of $-3.78 Million could theoretically repay -1% of its total liabilities ($3.32 Million) in one year. See cash generation quality of Benitec Biopharma Ltd ADR to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Benitec Biopharma Ltd ADR Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Benitec Biopharma Ltd ADR across 13 annual periods. Also explore BNTC net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Benitec Biopharma Ltd ADR (2013–2025)
Year-by-year debt coverage analysis for Benitec Biopharma Ltd ADR. For market capitalisation and broader financial context, see how much is Benitec Biopharma Ltd ADR worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -10.27x | $-23.59 Million | $2.30 Million | ▼ -162.6% |
| 2024 | -3.91x | $-19.40 Million | $4.96 Million | ▲ +7.5% |
| 2023 | -4.23x | $-18.01 Million | $4.26 Million | ▲ +17.8% |
| 2022 | -5.14x | $-15.90 Million | $3.09 Million | ▲ +45.1% |
| 2021 | -9.37x | $-12.83 Million | $1.37 Million | ▼ -87.3% |
| 2020 | -5.00x | $-7.54 Million | $1.51 Million | ▼ -375.5% |
| 2019 | 1.82x | $4.79 Million | $2.64 Million | ▲ +140.5% |
| 2018 | -4.49x | $-8.55 Million | $1.91 Million | ▲ +51.8% |
| 2017 | -9.32x | $-8.30 Million | $891.40K | ▲ +63.7% |
| 2016 | -25.70x | $-20.21 Million | $786.36K | ▼ -233.9% |
| 2015 | -7.70x | $-9.69 Million | $1.26 Million | ▼ -22.8% |
| 2014 | -6.27x | $-9.69 Million | $1.55 Million | ▲ +41.1% |
| 2013 | -10.64x | $-9.27 Million | $871.53K | — |